3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
2
Breast Neoplasms
2
Anatomic Stage III Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Renal Insufficiency, Chronic
1
Prostatic Neoplasms
1
Pleuropulmonary blastoma
1
Pain
1
Neuroblastoma
1
Melanoma
1
Leukemia, Hairy Cell
1
Ganglioneuroblastoma
1
Carcinoma, Renal Cell
1
Carcinoma, Medullary
1
Carcinoma, Intraductal, Noninfiltrating
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Interventions
Cyclophosphamide
16
fludarabine
9
Mycophenolic Acid
8
Cytarabine
8
venetoclax
7
Busulfan
7
fludarabine phosphate
6
Whole-Body Irradiation
6
Tacrolimus
5
Cyclosporine
5
ruxolitinib
4
ponatinib
4
Rituximab
4
Peripheral Blood Stem Cell Transplantation
4
Methotrexate
4
Etoposide
4
Daunorubicin
4
blinatumomab
3
asciminib
3
Vincristine
3
Prednisone
3
Mercaptopurine
3
Inotuzumab Ozogamicin
3
Dexamethasone
3
revumenib
2
pegfilgrastim
2
nilotinib
2
ibrutinib
2
Mesna
2
Melphalan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
High-Energy Shock Waves
×
90 days
×
Clear all
No trials found.